2613 (2613) Fair Value & Analysis

Industrials · Market cap HK$1.2B

2 2613 2613 · HK

PriceHK$30.66

Fair ValueHK$5.91

Upside-80.7%

Quality44/100

Watch 2613 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$2.55 – HK$5.91

Fair value as of: Jul 2, 2026

From 17 valuation models · updated today

Share price +0.2% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$23.50 – HK$37.02 · fair‑value band HK$2.55 – HK$5.91 · the HK$30.66 price screens above the HK$5.91 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2613 (2613) currently trades at HK$30.66, while our model-based Fair Value estimate is HK$5.91 — implying the stock looks roughly 80.7% overvalued today. We read business quality at 44/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 2613 generated revenue of HK$383M at a net margin of 1.5%. Revenue declined 13.8% year over year. It earns a return on equity of 1.1%. The balance sheet holds a net cash position of HK$94.7M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$383M

Revenue growth (YoY) -13.8%

Net margin 1.5%

Return on equity 1.1%

Free cash flow −HK$39.5M FY2025

P/E ratio 191.6

More key figures

Operating margin 9.2%

EPS (TTM) HK$0.1800

EPS growth (YoY) -93.6%

Net cash HK$94.7M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2613 reported revenue of HK$373M in FY2025 versus HK$141M in FY2021, a compound +27.7%/yr. Reported net income was HK$5.5M in FY2025, compounding −19.0%/yr from FY2021.

Revenue +27.7%/yr

FY21 HK$141M

FY22 HK$267M

FY23 HK$510M

FY24 HK$614M

FY25 HK$373M

Net income −19.0%/yr

FY21 HK$12.8M

FY22 HK$36.7M

FY23 HK$121M

FY24 HK$121M

FY25 HK$5.5M

Is 2613 fairly valued? → Check now

Similar stocks

6 more Aerospace & Defense stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
General Electric Company GE	C$46.59	C$22.78	-51%
RTX Corporation RTX	$180.99	$102.41	-43%
The Boeing Company BCO	€193.64	€48.20	-75%
Airbus SE EADSF	$219.00	$130.77	-40%
Safran SA SAFRY	$94.69	$58.09	-39%
Rolls-Royce Holdings RYCEY	$18.79	$9.46	-50%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2613 (2613) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$5.91 versus a price of HK$30.66 — about −81% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 2613?

Our model-based fair value for 2613 is HK$5.91 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$30.66.

What is the quality score of 2613?

2613 has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2613 (2613)?

2613 reported trailing-twelve-month revenue of about HK$383M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2613?

The net profit margin of 2613 is about 1.5%, meaning it keeps roughly 1.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.